desnitroimidacloprid and Neuroblastoma

desnitroimidacloprid has been researched along with Neuroblastoma* in 1 studies

Other Studies

1 other study(ies) available for desnitroimidacloprid and Neuroblastoma

ArticleYear
Acute effects of the imidacloprid metabolite desnitro-imidacloprid on human nACh receptors relevant for neuronal signaling.
    Archives of toxicology, 2021, Volume: 95, Issue:12

    Several neonicotinoids have recently been shown to activate the nicotinic acetylcholine receptor (nAChR) on human neurons. Moreover, imidacloprid (IMI) and other members of this pesticide family form a set of diverse metabolites within crops. Among these, desnitro-imidacloprid (DN-IMI) is of special toxicological interest, as there is evidence (i) for human dietary exposure to this metabolite, (ii) and that DN-IMI is a strong trigger of mammalian nicotinic responses. We set out here to quantify responses of human nAChRs to DN-IMI and an alternative metabolite, IMI-olefin. To evaluate toxicological hazards, these data were then compared to those of IMI and nicotine. Ca

    Topics: Alkenes; Animals; Cell Line; Cell Line, Tumor; Humans; Imidazolines; Molecular Docking Simulation; Neonicotinoids; Neuroblastoma; Neurons; Nicotinic Agonists; Nitro Compounds; Oocytes; Pesticides; Pyridines; Receptors, Nicotinic; Signal Transduction; Xenopus laevis

2021